Donald Craig Simonson, M.D., S.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Glucose | 77 | 2024 | 6391 | 1.800 |
Why?
|
Hyperglycemia | 16 | 2024 | 1376 | 1.780 |
Why?
|
Hypoglycemia | 24 | 2024 | 883 | 1.720 |
Why?
|
Diabetes Mellitus, Type 1 | 41 | 2023 | 3415 | 1.560 |
Why?
|
Hypoglycemic Agents | 19 | 2024 | 3085 | 1.420 |
Why?
|
Diabetes Mellitus, Type 2 | 42 | 2024 | 12149 | 1.270 |
Why?
|
Gastric Bypass | 8 | 2024 | 818 | 1.230 |
Why?
|
Insulin Resistance | 30 | 2024 | 3964 | 1.180 |
Why?
|
Insulin | 62 | 2022 | 6597 | 1.060 |
Why?
|
Adamantane | 2 | 2024 | 148 | 0.930 |
Why?
|
Dipeptides | 2 | 2024 | 391 | 0.860 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2024 | 467 | 0.790 |
Why?
|
Obesity, Morbid | 4 | 2022 | 1277 | 0.780 |
Why?
|
Bariatric Surgery | 5 | 2024 | 992 | 0.740 |
Why?
|
Hyperinsulinism | 5 | 2022 | 400 | 0.720 |
Why?
|
Glucosides | 2 | 2024 | 512 | 0.710 |
Why?
|
Gastroplasty | 2 | 2019 | 157 | 0.680 |
Why?
|
Benzhydryl Compounds | 3 | 2024 | 916 | 0.670 |
Why?
|
Diabetes Mellitus | 18 | 2024 | 5841 | 0.620 |
Why?
|
Gyrus Cinguli | 2 | 2022 | 1115 | 0.570 |
Why?
|
Epinephrine | 19 | 1999 | 792 | 0.560 |
Why?
|
Glutamic Acid | 2 | 2020 | 1176 | 0.520 |
Why?
|
Drug Therapy, Combination | 2 | 2024 | 6312 | 0.490 |
Why?
|
Glucagon | 18 | 1998 | 532 | 0.480 |
Why?
|
Insulin, Long-Acting | 1 | 2012 | 58 | 0.410 |
Why?
|
Glucose | 27 | 2023 | 4347 | 0.400 |
Why?
|
Vasodilation | 3 | 2006 | 962 | 0.400 |
Why?
|
Hydrocortisone | 15 | 1999 | 1819 | 0.390 |
Why?
|
Obesity | 14 | 2022 | 12947 | 0.390 |
Why?
|
Glipizide | 5 | 1998 | 48 | 0.380 |
Why?
|
Thiazolidinediones | 2 | 2006 | 461 | 0.380 |
Why?
|
Risk Reduction Behavior | 1 | 2018 | 1112 | 0.380 |
Why?
|
Intra-Abdominal Fat | 1 | 2014 | 613 | 0.330 |
Why?
|
Glucose Clamp Technique | 14 | 2010 | 263 | 0.330 |
Why?
|
Growth Hormone | 11 | 1996 | 569 | 0.320 |
Why?
|
Lipoproteins, HDL | 1 | 2013 | 676 | 0.320 |
Why?
|
Triglycerides | 5 | 2013 | 2461 | 0.310 |
Why?
|
Hormones | 3 | 1998 | 869 | 0.290 |
Why?
|
Laparoscopy | 1 | 2019 | 2036 | 0.280 |
Why?
|
Adult | 90 | 2024 | 221200 | 0.280 |
Why?
|
Weight Loss | 7 | 2019 | 2684 | 0.280 |
Why?
|
Glyburide | 7 | 1998 | 116 | 0.270 |
Why?
|
Middle Aged | 69 | 2024 | 220917 | 0.270 |
Why?
|
Adipose Tissue | 4 | 2013 | 3313 | 0.270 |
Why?
|
Male | 95 | 2024 | 360841 | 0.260 |
Why?
|
Quality of Life | 10 | 2019 | 13367 | 0.260 |
Why?
|
Norepinephrine | 13 | 1998 | 897 | 0.250 |
Why?
|
Memory, Short-Term | 1 | 2011 | 982 | 0.240 |
Why?
|
Female | 93 | 2024 | 392688 | 0.240 |
Why?
|
Adrenocorticotropic Hormone | 5 | 1999 | 618 | 0.230 |
Why?
|
Postprandial Period | 2 | 2024 | 315 | 0.230 |
Why?
|
Diabetes Complications | 4 | 2019 | 1315 | 0.220 |
Why?
|
Glucose Tolerance Test | 10 | 2013 | 1178 | 0.220 |
Why?
|
Fasting | 10 | 2021 | 1603 | 0.210 |
Why?
|
Bariatrics | 1 | 2023 | 36 | 0.210 |
Why?
|
Humans | 128 | 2024 | 761578 | 0.210 |
Why?
|
Liver | 17 | 2024 | 7527 | 0.200 |
Why?
|
Inositol | 1 | 2022 | 215 | 0.190 |
Why?
|
Lipids | 7 | 2014 | 3341 | 0.180 |
Why?
|
Naltrexone | 2 | 2013 | 317 | 0.180 |
Why?
|
Fatty Acids, Nonesterified | 9 | 2004 | 393 | 0.170 |
Why?
|
Life Style | 4 | 2019 | 3917 | 0.170 |
Why?
|
Serotonin | 1 | 2024 | 1041 | 0.170 |
Why?
|
Patient Satisfaction | 2 | 2012 | 3461 | 0.160 |
Why?
|
Metyrapone | 2 | 1996 | 22 | 0.160 |
Why?
|
Metformin | 2 | 2020 | 906 | 0.160 |
Why?
|
Overweight | 2 | 2022 | 2417 | 0.150 |
Why?
|
Androgen Antagonists | 2 | 2024 | 1410 | 0.150 |
Why?
|
Hypertension | 9 | 2006 | 8540 | 0.150 |
Why?
|
Insulin Infusion Systems | 5 | 1992 | 217 | 0.150 |
Why?
|
Hospitalization | 5 | 2024 | 10721 | 0.150 |
Why?
|
Aged | 30 | 2024 | 169308 | 0.140 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1651 | 0.140 |
Why?
|
Gastrectomy | 1 | 2022 | 672 | 0.140 |
Why?
|
beta-Endorphin | 1 | 1996 | 43 | 0.140 |
Why?
|
Benzodiazepines | 2 | 2013 | 1132 | 0.140 |
Why?
|
Patient Compliance | 1 | 2007 | 2690 | 0.140 |
Why?
|
Medication Reconciliation | 1 | 2018 | 153 | 0.130 |
Why?
|
Oxygen Consumption | 4 | 2012 | 1866 | 0.130 |
Why?
|
Adrenal Cortex | 1 | 1996 | 134 | 0.130 |
Why?
|
Thiazoles | 1 | 2003 | 1517 | 0.120 |
Why?
|
Jejunum | 1 | 2017 | 472 | 0.120 |
Why?
|
Vagotomy, Proximal Gastric | 1 | 2014 | 8 | 0.120 |
Why?
|
Reference Values | 10 | 2010 | 4920 | 0.120 |
Why?
|
Homeostasis | 7 | 2013 | 3323 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2024 | 64684 | 0.120 |
Why?
|
Metabolome | 1 | 2021 | 989 | 0.120 |
Why?
|
Prolactin | 1 | 1996 | 625 | 0.120 |
Why?
|
Body Mass Index | 11 | 2024 | 12953 | 0.120 |
Why?
|
Brain | 6 | 2017 | 27121 | 0.120 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2014 | 86 | 0.110 |
Why?
|
Synaptic Transmission | 1 | 2020 | 1173 | 0.110 |
Why?
|
Anastomosis, Surgical | 1 | 2017 | 983 | 0.110 |
Why?
|
Brachial Artery | 2 | 2006 | 366 | 0.110 |
Why?
|
Access to Information | 1 | 2016 | 316 | 0.110 |
Why?
|
Endothelins | 1 | 1993 | 127 | 0.110 |
Why?
|
India | 3 | 2006 | 2348 | 0.110 |
Why?
|
Deferoxamine | 1 | 1993 | 155 | 0.110 |
Why?
|
Pituitary Gland | 1 | 1996 | 635 | 0.110 |
Why?
|
Young Adult | 10 | 2022 | 59254 | 0.100 |
Why?
|
Sulfonylurea Compounds | 3 | 2020 | 219 | 0.100 |
Why?
|
Diabetic Angiopathies | 2 | 1988 | 803 | 0.100 |
Why?
|
Hypothalamus | 2 | 2008 | 999 | 0.100 |
Why?
|
Basal Ganglia | 1 | 2015 | 554 | 0.100 |
Why?
|
Cerebrum | 1 | 2013 | 132 | 0.100 |
Why?
|
Hospital Mortality | 2 | 2024 | 5293 | 0.100 |
Why?
|
Patient Participation | 1 | 2021 | 1445 | 0.100 |
Why?
|
Nerve Net | 2 | 2015 | 2291 | 0.100 |
Why?
|
Body Temperature Regulation | 3 | 1990 | 292 | 0.100 |
Why?
|
Prefrontal Cortex | 2 | 2015 | 2220 | 0.100 |
Why?
|
Bone Remodeling | 1 | 2015 | 581 | 0.100 |
Why?
|
Appetite Depressants | 1 | 2012 | 108 | 0.100 |
Why?
|
Glutamine | 2 | 2009 | 577 | 0.100 |
Why?
|
Emergencies | 1 | 2018 | 1217 | 0.100 |
Why?
|
Cognition Disorders | 4 | 2017 | 3980 | 0.100 |
Why?
|
Proteome | 1 | 2021 | 1862 | 0.100 |
Why?
|
Human Growth Hormone | 4 | 2021 | 642 | 0.100 |
Why?
|
Prediabetic State | 1 | 2017 | 545 | 0.090 |
Why?
|
Counseling | 1 | 2019 | 1547 | 0.090 |
Why?
|
Antiporters | 1 | 1992 | 277 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10212 | 0.090 |
Why?
|
Menstrual Cycle | 2 | 1992 | 539 | 0.090 |
Why?
|
Phentolamine | 3 | 1987 | 102 | 0.090 |
Why?
|
Arginine | 1 | 1994 | 934 | 0.090 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2017 | 874 | 0.090 |
Why?
|
Prostatic Neoplasms | 2 | 2024 | 11122 | 0.090 |
Why?
|
Injections, Subcutaneous | 3 | 2007 | 681 | 0.090 |
Why?
|
Ferritins | 1 | 1993 | 598 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 11 | 2020 | 36426 | 0.090 |
Why?
|
Sodium, Dietary | 2 | 1994 | 425 | 0.090 |
Why?
|
Calorimetry | 1 | 1990 | 129 | 0.090 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2319 | 0.090 |
Why?
|
Acute Disease | 2 | 2020 | 7237 | 0.090 |
Why?
|
Ambulatory Care | 2 | 2018 | 2775 | 0.090 |
Why?
|
Patient Readmission | 1 | 2024 | 3271 | 0.090 |
Why?
|
C-Peptide | 7 | 1997 | 440 | 0.080 |
Why?
|
Emergency Service, Hospital | 3 | 2018 | 7879 | 0.080 |
Why?
|
Propranolol | 4 | 1987 | 489 | 0.080 |
Why?
|
Antihypertensive Agents | 3 | 1998 | 2024 | 0.080 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39107 | 0.080 |
Why?
|
Lipid Metabolism | 4 | 2013 | 1902 | 0.080 |
Why?
|
Cost of Illness | 1 | 1998 | 1936 | 0.080 |
Why?
|
Fructose | 2 | 1988 | 288 | 0.080 |
Why?
|
Drug Administration Schedule | 2 | 2007 | 4853 | 0.080 |
Why?
|
Health Services Research | 1 | 1996 | 1812 | 0.080 |
Why?
|
Body Weight | 3 | 2017 | 4618 | 0.080 |
Why?
|
Cerebral Cortex | 2 | 2015 | 5779 | 0.080 |
Why?
|
Affect | 2 | 1999 | 1486 | 0.080 |
Why?
|
Emotions | 1 | 2020 | 2739 | 0.080 |
Why?
|
Case-Control Studies | 5 | 2017 | 22176 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2018 | 1421 | 0.070 |
Why?
|
Narcotic Antagonists | 1 | 2012 | 585 | 0.070 |
Why?
|
Computers | 2 | 1990 | 593 | 0.070 |
Why?
|
Executive Function | 1 | 2015 | 1392 | 0.070 |
Why?
|
Administration, Sublingual | 1 | 2006 | 59 | 0.070 |
Why?
|
Cross-Over Studies | 1 | 2012 | 2079 | 0.070 |
Why?
|
Vanadates | 2 | 1995 | 82 | 0.070 |
Why?
|
Cognition | 4 | 2017 | 6992 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2024 | 80646 | 0.060 |
Why?
|
Carbohydrates | 1 | 1988 | 390 | 0.060 |
Why?
|
Primary Health Care | 2 | 2019 | 4686 | 0.060 |
Why?
|
Cardiovascular Diseases | 4 | 2019 | 15502 | 0.060 |
Why?
|
Physical Exertion | 2 | 1987 | 667 | 0.060 |
Why?
|
Nitroglycerin | 1 | 2006 | 329 | 0.060 |
Why?
|
Hyperemia | 1 | 2006 | 221 | 0.060 |
Why?
|
Carrier Proteins | 2 | 2021 | 4937 | 0.060 |
Why?
|
Double-Blind Method | 7 | 2020 | 12341 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2024 | 58983 | 0.060 |
Why?
|
Occupations | 1 | 2007 | 515 | 0.060 |
Why?
|
Energy Intake | 1 | 2012 | 2134 | 0.060 |
Why?
|
Dexamethasone | 1 | 1992 | 1948 | 0.060 |
Why?
|
Energy Metabolism | 4 | 1990 | 2882 | 0.060 |
Why?
|
Muscle, Skeletal | 2 | 2024 | 4948 | 0.060 |
Why?
|
Subcutaneous Tissue | 1 | 2004 | 132 | 0.060 |
Why?
|
Administration, Inhalation | 1 | 2007 | 1157 | 0.060 |
Why?
|
Radioimmunoassay | 2 | 1995 | 861 | 0.050 |
Why?
|
Analysis of Variance | 6 | 1997 | 6228 | 0.050 |
Why?
|
Sleep Deprivation | 1 | 2010 | 846 | 0.050 |
Why?
|
Erythrocytes | 1 | 1992 | 2413 | 0.050 |
Why?
|
Information Systems | 1 | 1985 | 396 | 0.050 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2009 | 1141 | 0.050 |
Why?
|
Kinetics | 11 | 1998 | 6374 | 0.050 |
Why?
|
Antipsychotic Agents | 2 | 2013 | 3067 | 0.050 |
Why?
|
Dipeptidases | 1 | 2021 | 38 | 0.050 |
Why?
|
Weight Gain | 1 | 2012 | 2348 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2021 | 68 | 0.050 |
Why?
|
Vasodilator Agents | 1 | 2006 | 973 | 0.050 |
Why?
|
Risk Factors | 8 | 2024 | 74212 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2021 | 127 | 0.050 |
Why?
|
Delayed-Action Preparations | 2 | 2012 | 962 | 0.050 |
Why?
|
Neuropsychological Tests | 5 | 2014 | 7054 | 0.040 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2001 | 277 | 0.040 |
Why?
|
Endothelium, Vascular | 2 | 2006 | 4431 | 0.040 |
Why?
|
Leucine | 3 | 1998 | 548 | 0.040 |
Why?
|
Blood Pressure | 5 | 2003 | 8481 | 0.040 |
Why?
|
Eating | 1 | 2007 | 1539 | 0.040 |
Why?
|
Diet, Reducing | 2 | 2014 | 485 | 0.040 |
Why?
|
Exercise | 1 | 2016 | 5890 | 0.040 |
Why?
|
Self-Assessment | 2 | 1998 | 397 | 0.040 |
Why?
|
Time Factors | 8 | 2019 | 39970 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5440 | 0.040 |
Why?
|
Amlodipine | 1 | 1998 | 84 | 0.040 |
Why?
|
Sex Factors | 4 | 1999 | 10554 | 0.040 |
Why?
|
Adiponectin | 1 | 2004 | 1113 | 0.040 |
Why?
|
Nifedipine | 1 | 1998 | 221 | 0.040 |
Why?
|
Abdomen | 1 | 2004 | 1128 | 0.040 |
Why?
|
Phosphates | 1 | 1982 | 770 | 0.040 |
Why?
|
Glucosamine | 1 | 1998 | 128 | 0.040 |
Why?
|
Aging | 3 | 1994 | 8711 | 0.040 |
Why?
|
Infusions, Intravenous | 3 | 1993 | 2217 | 0.040 |
Why?
|
Diabetic Retinopathy | 2 | 1996 | 1274 | 0.040 |
Why?
|
Sodium | 3 | 1993 | 1588 | 0.040 |
Why?
|
Absenteeism | 1 | 1998 | 247 | 0.040 |
Why?
|
Body Composition | 2 | 2024 | 2426 | 0.030 |
Why?
|
Calorimetry, Indirect | 3 | 2010 | 174 | 0.030 |
Why?
|
Remission Induction | 1 | 2022 | 2397 | 0.030 |
Why?
|
Digestive System | 1 | 1997 | 244 | 0.030 |
Why?
|
Potassium | 2 | 1993 | 1311 | 0.030 |
Why?
|
Hydroxycholecalciferols | 1 | 2015 | 44 | 0.030 |
Why?
|
Prostatectomy | 1 | 2024 | 1824 | 0.030 |
Why?
|
Pilot Projects | 3 | 2017 | 8633 | 0.030 |
Why?
|
Prospective Studies | 4 | 2024 | 54423 | 0.030 |
Why?
|
Pancreatic Hormones | 1 | 1995 | 12 | 0.030 |
Why?
|
Androgens | 1 | 2023 | 1286 | 0.030 |
Why?
|
Calcium Channel Blockers | 1 | 1998 | 694 | 0.030 |
Why?
|
Metabolomics | 1 | 2024 | 1659 | 0.030 |
Why?
|
Awareness | 1 | 1999 | 648 | 0.030 |
Why?
|
Schizophrenia | 1 | 2013 | 6937 | 0.030 |
Why?
|
Pressoreceptors | 1 | 1994 | 99 | 0.030 |
Why?
|
Hepatocytes | 1 | 2021 | 1233 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2023 | 1520 | 0.030 |
Why?
|
Puberty | 2 | 1989 | 501 | 0.030 |
Why?
|
Psychomotor Performance | 2 | 1995 | 1882 | 0.030 |
Why?
|
Sympathetic Nervous System | 2 | 1990 | 518 | 0.030 |
Why?
|
Follicular Phase | 2 | 1992 | 143 | 0.030 |
Why?
|
Luteal Phase | 2 | 1992 | 138 | 0.030 |
Why?
|
Automobile Driving | 1 | 1999 | 441 | 0.030 |
Why?
|
Recurrence | 2 | 2014 | 8466 | 0.030 |
Why?
|
Lost to Follow-Up | 1 | 2014 | 123 | 0.030 |
Why?
|
Anisotropy | 1 | 2017 | 1283 | 0.030 |
Why?
|
Age Factors | 4 | 2014 | 18398 | 0.030 |
Why?
|
United States | 4 | 2014 | 72335 | 0.030 |
Why?
|
Radiography | 1 | 2004 | 6965 | 0.030 |
Why?
|
Single-Blind Method | 1 | 1997 | 1574 | 0.030 |
Why?
|
Osmolar Concentration | 4 | 1998 | 659 | 0.030 |
Why?
|
Oxidation-Reduction | 5 | 1994 | 2231 | 0.030 |
Why?
|
Placebos | 1 | 1997 | 1667 | 0.030 |
Why?
|
Neural Pathways | 2 | 2013 | 3060 | 0.030 |
Why?
|
Data Collection | 2 | 1996 | 3322 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2013 | 523 | 0.020 |
Why?
|
Appetite Regulation | 1 | 2012 | 84 | 0.020 |
Why?
|
Physical Fitness | 1 | 2016 | 743 | 0.020 |
Why?
|
Body Temperature | 2 | 1986 | 781 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2012 | 413 | 0.020 |
Why?
|
Regression Analysis | 2 | 1998 | 6344 | 0.020 |
Why?
|
Angiotensin II | 1 | 1994 | 849 | 0.020 |
Why?
|
Rats | 2 | 2021 | 23741 | 0.020 |
Why?
|
Software | 1 | 1985 | 4434 | 0.020 |
Why?
|
Ultrasonography | 1 | 2004 | 5971 | 0.020 |
Why?
|
Health Status | 2 | 1998 | 4077 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2012 | 554 | 0.020 |
Why?
|
Renin | 1 | 1993 | 641 | 0.020 |
Why?
|
Lactates | 1 | 1991 | 405 | 0.020 |
Why?
|
Disease Management | 1 | 2021 | 2508 | 0.020 |
Why?
|
Health Status Indicators | 1 | 1996 | 970 | 0.020 |
Why?
|
Proteins | 2 | 2004 | 6032 | 0.020 |
Why?
|
Cohort Studies | 3 | 2023 | 41493 | 0.020 |
Why?
|
Retinal Vessels | 1 | 1996 | 852 | 0.020 |
Why?
|
Adolescent | 10 | 2007 | 88323 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2008 | 26127 | 0.020 |
Why?
|
Intelligence | 1 | 1995 | 924 | 0.020 |
Why?
|
Depression | 1 | 2009 | 8124 | 0.020 |
Why?
|
Brain Mapping | 2 | 2015 | 6635 | 0.020 |
Why?
|
Basal Metabolism | 1 | 2010 | 161 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2015 | 1803 | 0.020 |
Why?
|
Carbohydrate Metabolism | 1 | 1990 | 263 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 1989 | 361 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2012 | 1848 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1994 | 1492 | 0.020 |
Why?
|
Aldosterone | 1 | 1993 | 870 | 0.020 |
Why?
|
Stimulation, Chemical | 2 | 1989 | 306 | 0.020 |
Why?
|
Insulin-Secreting Cells | 1 | 2015 | 901 | 0.020 |
Why?
|
Cluster Analysis | 1 | 1995 | 2707 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 2395 | 0.020 |
Why?
|
Memory | 1 | 2017 | 2193 | 0.020 |
Why?
|
Drug Interactions | 1 | 2012 | 1416 | 0.020 |
Why?
|
Leg | 1 | 2012 | 1088 | 0.020 |
Why?
|
Autonomic Nervous System | 1 | 1992 | 703 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1998 | 3713 | 0.020 |
Why?
|
Insulin Antibodies | 2 | 1987 | 28 | 0.020 |
Why?
|
Thalassemia | 1 | 1988 | 267 | 0.020 |
Why?
|
Monocytes | 3 | 1985 | 2570 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3873 | 0.020 |
Why?
|
Cholesterol | 3 | 1999 | 2905 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3511 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1997 | 10766 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2018 | 1923 | 0.020 |
Why?
|
Lactic Acid | 1 | 1991 | 1139 | 0.020 |
Why?
|
Metoprolol | 1 | 1986 | 90 | 0.020 |
Why?
|
Thalamus | 1 | 2012 | 1047 | 0.020 |
Why?
|
Dopamine | 1 | 1993 | 1607 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2012 | 1420 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2018 | 3600 | 0.020 |
Why?
|
Arteriosclerosis | 1 | 1990 | 1055 | 0.020 |
Why?
|
Patient Discharge | 1 | 2018 | 3443 | 0.020 |
Why?
|
Animals | 5 | 2024 | 168475 | 0.020 |
Why?
|
Bone and Bones | 1 | 2015 | 2568 | 0.020 |
Why?
|
Health Behavior | 1 | 2016 | 2644 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2006 | 17904 | 0.010 |
Why?
|
Depression, Chemical | 1 | 1984 | 184 | 0.010 |
Why?
|
Temporal Lobe | 1 | 2012 | 1695 | 0.010 |
Why?
|
Receptors, Adrenergic, alpha | 1 | 1984 | 146 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2012 | 1878 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3205 | 0.010 |
Why?
|
Reoperation | 1 | 2014 | 4303 | 0.010 |
Why?
|
Leptin | 1 | 2012 | 1597 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2014 | 2639 | 0.010 |
Why?
|
Models, Theoretical | 1 | 1996 | 3575 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 1996 | 14665 | 0.010 |
Why?
|
Tritium | 1 | 1984 | 708 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11904 | 0.010 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1984 | 242 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5247 | 0.010 |
Why?
|
Health Care Costs | 1 | 2016 | 3242 | 0.010 |
Why?
|
Wakefulness | 1 | 2010 | 1265 | 0.010 |
Why?
|
Diffusion Tensor Imaging | 1 | 2013 | 2400 | 0.010 |
Why?
|
Perception | 2 | 1999 | 1197 | 0.010 |
Why?
|
Child | 5 | 2007 | 80157 | 0.010 |
Why?
|
Central Nervous System Stimulants | 1 | 2010 | 1177 | 0.010 |
Why?
|
Amino Acids | 1 | 1987 | 1718 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8656 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 1996 | 20099 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21355 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2006 | 2927 | 0.010 |
Why?
|
Alanine | 1 | 1983 | 609 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1987 | 2112 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2006 | 1814 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2012 | 3188 | 0.010 |
Why?
|
Attention | 1 | 2010 | 2396 | 0.010 |
Why?
|
Creatinine | 1 | 1985 | 1899 | 0.010 |
Why?
|
Hippocampus | 1 | 2012 | 3766 | 0.010 |
Why?
|
Keto Acids | 2 | 1990 | 35 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2009 | 3769 | 0.010 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 1985 | 1119 | 0.010 |
Why?
|
Rheumatology | 1 | 1985 | 615 | 0.010 |
Why?
|
Attitude to Health | 1 | 1988 | 2025 | 0.010 |
Why?
|
Imino Pyranoses | 1 | 1998 | 4 | 0.010 |
Why?
|
1-Deoxynojirimycin | 1 | 1998 | 18 | 0.010 |
Why?
|
Psychotic Disorders | 1 | 2013 | 3223 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2001 | 20569 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4244 | 0.010 |
Why?
|
Methacholine Chloride | 1 | 1998 | 220 | 0.010 |
Why?
|
Verapamil | 1 | 1998 | 242 | 0.010 |
Why?
|
Diabetic Ketoacidosis | 1 | 1981 | 253 | 0.010 |
Why?
|
Spain | 1 | 1998 | 487 | 0.010 |
Why?
|
Mice | 1 | 2024 | 81539 | 0.010 |
Why?
|
Octreotide | 1 | 1998 | 153 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2006 | 2382 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2014 | 4811 | 0.010 |
Why?
|
Phenylalanine | 1 | 1998 | 366 | 0.010 |
Why?
|
Calibration | 1 | 1998 | 818 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9469 | 0.010 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 1995 | 203 | 0.010 |
Why?
|
Somatostatin | 1 | 1997 | 447 | 0.010 |
Why?
|
Islets of Langerhans | 2 | 1995 | 1341 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1995 | 489 | 0.010 |
Why?
|
Glycogen | 1 | 1994 | 251 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 1995 | 477 | 0.010 |
Why?
|
Mental Health | 1 | 1988 | 3250 | 0.010 |
Why?
|
Food | 1 | 1998 | 774 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 23996 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1996 | 1496 | 0.010 |
Why?
|
Diet | 1 | 1990 | 8075 | 0.010 |
Why?
|
Fluorescein Angiography | 1 | 1996 | 1059 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 2 | 1989 | 1935 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1985 | 8002 | 0.010 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 1989 | 241 | 0.000 |
Why?
|
Quality Assurance, Health Care | 1 | 1998 | 2169 | 0.000 |
Why?
|
Dehydroepiandrosterone | 1 | 1989 | 258 | 0.000 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 1987 | 68 | 0.000 |
Why?
|
Drug Delivery Systems | 1 | 1998 | 2226 | 0.000 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1995 | 2425 | 0.000 |
Why?
|
Prognosis | 1 | 2006 | 29629 | 0.000 |
Why?
|
Bicarbonates | 1 | 1987 | 292 | 0.000 |
Why?
|
Retina | 1 | 1996 | 2659 | 0.000 |
Why?
|
Glycolysis | 1 | 1988 | 835 | 0.000 |
Why?
|
Catecholamines | 1 | 1984 | 386 | 0.000 |
Why?
|
Receptor, Insulin | 1 | 1985 | 836 | 0.000 |
Why?
|
Blood Transfusion | 1 | 1988 | 1301 | 0.000 |
Why?
|
Perfusion | 1 | 1985 | 1373 | 0.000 |
Why?
|
Dogs | 1 | 1985 | 3839 | 0.000 |
Why?
|
Administration, Oral | 1 | 1988 | 4021 | 0.000 |
Why?
|
Pregnancy | 1 | 1989 | 29876 | 0.000 |
Why?
|